Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension Phase 3 trial of ustekinumab in pediatric patients is being conducted for Crohn's disease and ulcerative colitis, with a…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 [Phase 3]
This is a Phase 3 maintenance and long-term extension study evaluating the efficacy and safety of upadacitinib (ABT-494) in Crohn's disease …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery [Phase 3]
A completed Phase 3 trial evaluating perioperative hemodynamic optimization using photoplethysmography in colorectal surgery, sponsored by U…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
Clinical trial update indicating a completed study evaluating infections in adults with Ulcerative Colitis or Crohn's Disease.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Open-label Extension Study of Brazikumab in Crohn's Disease [Phase 3]
An open-label extension of Brazikumab in Crohn's Disease (Phase 3) has been terminated, with results posted on 2026-04-01.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 induction study is evaluating the efficacy and safety of Duvakitug in participants with moderately to severely active Crohn's dise…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease [NA]
A clinical trial evaluating cyclic exclusive enteral nutrition as maintenance therapy for pediatric Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue. [NA]
A clinical trial update on treating complex perianal fistulas in Crohn's disease using local injection of micro-fragmented autologous adipos…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease [Phase 3]
A pediatric Phase 3 trial of mirikizumab (LY3074828) for Crohn's disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 2]
Phase 2 pediatric trial evaluating the long-term safety of intravenous vedolizumab in children with ulcerative colitis or Crohn's disease; r…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease [Phase 3]
Phase 3 trial evaluating PROCHYMAL for treatment-refractory moderate-to-severe Crohn's disease has completed. The sponsor was Mesoblast, and…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease [Phase 3]
An extended Phase 3 evaluation of PROCHYMAL adult human stem cells for treatment-resistant Crohn's disease has completed, according to Mesob…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease [Phase 2, Phase 3]
A Phase 2/3 trial evaluating personalized, model-informed induction dosing of infliximab in Crohn's disease has been terminated with results…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease [Phase 3]
A Phase 3 trial evaluating PROCHYMAL (allogeneic mesenchymal stem cells) for treatment-resistant moderate-to-severe Crohn's disease has comp…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Effect of Grapes in Inflammatory Bowel Disease [NA]
A completed clinical trial investigated the effect of grapes as a dietary intervention for inflammatory bowel disease, focusing on Crohn's d…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA
Takeda is providing expanded access to vedolizumab for children and teenagers with Crohn's disease or ulcerative colitis in the United State…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Pilot Study of Posaconazole in Crohn's Disease [Phase 4]
A Phase 4 pilot study of posaconazole in Crohn's disease with the CARD9 S12N risk allele was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease [Phase 1]
Phase 1 study of PALI-2108 in healthy volunteers and patients with ulcerative colitis or fibrostenosing Crohn's disease is active but not re…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Safety Study of P28GST Treatment in Crohn's Disease Patients [Phase 2]
A Phase 2 safety study of P28GST in Crohn's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease [Phase 4]
A Phase 4 clinical trial is evaluating a combination of palmitoleic acid with infliximab to promote intestinal mucosal healing in Crohn's di…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy
A completed clinical trial evaluated tissue cytomegalovirus viral load and associated factors in pediatric patients undergoing colonoscopy, …
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU [NA]
A completed clinical trial evaluating telemonitoring in the management of complex inflammatory bowel disease (Crohn's disease and ulcerative…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
A completed clinical trial comparing non-injected MR enterography with a conventional contrast-enhanced MR enterography protocol to assess p…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula [Phase 4]
A Phase 4 study of darvadstrocel (Alofisel) in adults with Crohn's disease and complex perianal fistula was terminated; results have been po…